Abstract
Platelets of full-term newborns and those of healthy adult donors were compared for constitutive expression of surface glycoproteins (GP) Ia-IIa, GP Ib, GP IIb-IIIa, and GP IV and for their activation responses to an agonist by detection of surface expression of activation markers P-selectin and CD63. Resting neonatal platelets showed significantly lower expression of GP Ia-IIa, GP Ib, and GP IIb-IIIa. In contrast, the expression of GP IV was significantly higher compared with platelets of adults. The expression of activation markers P-selectin and CD63 was assessed after in vitro activating of platelets with 0–15 μM human thrombin receptor-activating peptide. At low concentrations of thrombin receptor-activating peptide, the extent of surface expression of activation markers did not differ significantly between adult and neonatal platelets. However, after activation with 15 μM thrombin receptor-activating peptide, the extent of surface expression of P-selectin and CD63 was significantly lower in neonatal platelets. Because of ethical reasons, our study was conducted on neonates with a moderate neonatal hyperbilirubinemia. The remote possibility that hyperbilirubinemia could influence the expression of platelet surface receptors and the reactivity of neonatal platelet cannot be excluded. The role of higher expression of GP IV on neonatal platelets, also seen in certain hematologic malignancies in adults, remains to be elucidated. The lower expression of platelet adhesive receptors and the limited ability to up-regulate granular glycoproteins may play a role in the impairment of function of neonatal platelets.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CD:
-
cluster of differentiation
- GP:
-
glycoprotein
- PE:
-
phycoerythrin
- TRAP:
-
thrombin receptor-activating peptide
References
Hrodek O 1969 Platelet aggregation in the newborn infant. Nouv Rev Fr Hematol 9: 569–573.
Israels SJ, Daniels M, McMillan EM 1990 Deficient collagen-induced activation in the newborn platelet. Pediatr Res 27: 337–343.
Michelson AD 1994 Neonatal thrombosis and hemorrhage. In: Loscalzo J, Schafer AI (eds) Thrombosis and Hemorrhage. Blackwell, Cambridge, 999–1026.
Andrews P, Broughton Pipkin F, Heptinstall S 1985 Blood platelet behavior in mothers and neonates. Thromb Haemost 53: 428–432.
Suarez CR, Gonzales J, Mendez C, Fareed J, Fresco R, Walenga J 1988 Neonatal and maternal platelets: activation at time of birth. Am J Hematol 29: 18–21.
Gader AMA, Bahakim H, Jabbar FA, Lambourne AL, Gaafar TH, Endrees YB 1988 Dose-response aggregometry in maternal-neonatal platelets. Thromb Haemost 60: 314–318.
Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD 1994 Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 72: 957–963.
Kühne T, Ryan G, Blanchette V, Semple JW, Hornstein A, Mody M, Chang W, McWhirter L, Freedman J 1996 Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants. Pediatr Res 40: 876–880.
Meher-Hojmi NJ, Montemagno R, Thilaganathan B, Nicolaides KH 1994 Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood. Am J Obstet Gynecol 171: 791–796.
Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD 1997 Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 77: 1002–1007.
Gatti L, Guarneri D, Caccamo ML, Gianotti GA, Marini A 1996 Platelet activation in newborns detected by flow cytometry. Biol Neonate 70: 322–327.
Brass LF, Vassallo RR Jr, Belmonte E, Ahuja M, Cichowski K, Hoxie JA 1992 Structure and function of the human platelet thrombin receptor. J Biol Chem 267: 13795–13798.
Nieuwenhuis HK, Sakariassen KS, Houdijk WPM, Nievelstein PFEM, Sixma JJ 1985 Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470–472.
Coller BS, Beer JH, Scudder LE, Steinberg MH 1989 Collagen-platelet interactions: evidence for indirect interaction of collagen with platelet adhesion GPIa/IIa and an indirect interaction with GPIIb/IIIa mediated by adhesive proteins. Blood 74: 182–192.
Lopez JA 1994 The platelet Ib-IX complex. Blood Coagul Fibrinolysis 5: 97–119.
Clemetson KJ 1997 Platelet GPIb-V-IX complex. Thromb Haemost 78: 256–260.
Coller BS 1986 Mechanisms of exposure of the GPIIb/IIIa complex receptor for adhesive glycoproteins. In: McGregor JL (ed) Monoclonal Antibodies and Human Blood Platelets. Elsevier Science, Amsterdam, 93–102.
Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA 1992 Membrane glycoprotein CD36: : a review of its role in adherence, signal transduction, and transfusion medicine. Blood 80: 1105–1115.
Asch AS, Liu I, Bricetti FM, Barnwell J, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M 1993 Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science 262: 1436–1441.
Berger G, Caen JP, Berndt MC, Cramer EM 1993 Ultrastructural demonstration of CD 36 in the alpha-granule membrane of human platelets and megakaryocytes. Blood 82: 3034–3044.
Michelson AD, Wencel-Drake JD, Kestin AS, Barnard MR 1994 Platelet activation results in a redistribution of glycoprotein IV (CD36). Arterioscler Thromb 14: 1193–1201.
Daviet L, McGregor JL 1997 Vascular biology of CD36: : roles of this new adhesion molecule family in different disease states. Thromb Haemost 78: 65–69.
Coller BS 1989 Activation-specific platelet antigens. In: Kunicki TJ, George JN (eds) Platelet Immunobiology: Molecular and Clinical Aspects. JB Lippincott, Philadelphia, 166–189.
McEver RP 1991 GMP 140: : a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 45: 156–161.
Nishibori M, Cham B, McNicol A, Shalev A, Jain N, Gerrard JM 1993 The protein CD63 is in platelet-dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest 91: 1775–1782.
Niewenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ 1987 Studies with monoclonal antibody against activated platelets: : evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70: 838–845.
Thibert V, Bellucci S, Cristofari M, Gluckman E, Legrand C 1995 Increased platelet CD36 constitutes a common marker in myeloproliferative disorders. Br J Haematol 91: 618–624.
Lasne D, Donato J, Falet H, Rendu F 1995 Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction. Thromb Haemost 74: 1323–1328.
Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Graham Knight C, Farndale RW, Okuma M, Barnes MJ 1998 Glycoprotein VI is a major receptor for platelet activation: : it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 91: 491–499.
Lozano M, Escolar G, White JG, Tassies D, Ordinas A, Diaz-Ricart M 1996 Redistribution of membrane glycoproteins in platelets activated under flow conditions. Blood Coagul Fibrinolysis 7: 214–217.
Michelson AD, Wencel-Drake JD, Kestin AS, Barnard MR 1994 Platelet activation results in a redistribution of glycoprotein IV (CD36). Arterioscler Thromb 14: 1193–1201.
Berger G, Caen JP, Berndt MC, Cramer EM 1993 Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes. Blood 82: 3034–3044.
Tanindi S, Kurekci AE, Koseoglu V, Kurt M, Ozcan O 1995 The normalization period of platelet aggregation in newborns. Thromb Res 80: 57–62.
American Academy of Pediatrics 1994 Practice parameter: : management of hyperbilirubinemia in the healthy term newborn. Pediatrics 94: 558–565.
Karim MAG, Clelland IA, Chapman IV, Walker CHM 1981 β-Thromboglobulin levels in plasma of jaundiced neonates exposed to phototherapy. J Perinat Med 9: 141–144.
Kaapa P 1985 Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1α in neonatal hyperbilirubinemia. Prostaglandins Leukot Med 17: 97–105.
Acknowledgements
The authors thank Dr. Jaroslav G. Vostal and Prof. František Kornalík for review of manuscript and helpful discussion.
Author information
Authors and Affiliations
Additional information
Supported by grant 3051–3 of the IGA MH of the Czech Republic.
Rights and permissions
About this article
Cite this article
Šimák, J., Holada, K., Janota, J. et al. Surface Expression of Major Membrane Glycoproteins on Resting and TRAP-Activated Neonatal Platelets. Pediatr Res 46, 445 (1999). https://doi.org/10.1203/00006450-199910000-00014
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199910000-00014
